FOR INVESTMENTS

Projects/companies for investments.

1. Russian federation based company.

Therapeutic target: cancer
Technology: GENE DIRECTED ENZYME PRODRUG GENE THERAPY (GDEPT) – based on non-viral vector.
Patents: granted.
Stage: preclinical successfully completed;
Next stage: clinical trials stage I.
Looking for: funding.

2. Israeli company.

Therapeutic target: bacterial infections (gram-positive) resistant to known antibiotic agents (including MRSA);
Technology: a new chemical entity with a novel unique mechanism of action demonstrating high synergism when administered with approved antibiotic therapies.
Patents: submitted and some granted;
Stage: preclinical
Looking: the strategic partner for development. Preferably, the company already active in the infection disorders area)

3. Israeli company.

Therapeutic target: bones reconstitution and mineralization (medical device);
Technology: the combination of unique self-assembling polymer and Tricalcium Phosphate;
Primary commercial target: Dentistry – Peri-implantitis.
Patents: Granted
Stage: development.
Looking for: funding.

Calathea Pharma Ltd. proud to announce: our assistance to Israeli company developing new techniques for bone reconstitution and mineralization, brought positive results. The first round of funding successfully completed.

For more investment opportunities, please, review the list and follow us at LinkedIn.

4. Israeli company

Searching for funding for ” Development of an industrial process for the preparation of Steviol (natural sweetener presents in Stevia) from alternative sources by the implementation of green chemistry approach”

5. Israeli company

invented a new  optical device and algorithm for earlier and accurate diagnostic of Skin Melanoma;

6. Israeli company

discovered new unique therapeutic target and therapeutic agent for the treatment of solid tumors (Pancreatic cancer)- preclinical stage;

7. Czech company

with diversified portfolio of complex API’s and FDF (paragraph IV opportunity) – for details, please, contact us.